IMCD Management
Management criteria checks 4/4
IMCD's CEO is Marcus Jordan, appointed in May 2022, has a tenure of 4.33 years. total yearly compensation is €1.73M, comprised of 44.7% salary and 55.3% bonuses, including company stock and options. directly owns 0.027% of the company’s shares, worth €1.55M. The average tenure of the management team and the board of directors is 2.2 years and 5.3 years respectively.
Key information
Marcus Jordan
Chief executive officer
€1.7m
Total compensation
| CEO salary percentage | 44.70% |
| CEO tenure | 4.3yrs |
| CEO ownership | 0.03% |
| Management average tenure | 2.2yrs |
| Board average tenure | 5.3yrs |
Recent management updates
Recent updates
Narrative Update • Aug 21
IMCD: Elevated Multiple Will Constrain Returns If Earnings Execution Disappoints
Analysts have raised their fair value estimate for IMCD from €79.37 to €85.58, reflecting recent price target increases to €100, €110 and €123. These changes are linked to updated views on earnings potential, discount rate assumptions and a slightly higher future P/E of 21.29x.
Narrative Update • Aug 07
IMCD: Global Expansion And Margin Strength Will Support Future Upside
The updated analyst price target for IMCD moves from about €112.50 to roughly €116.60, as analysts weigh slightly lower revenue growth expectations against firmer profit margin assumptions, together with a mixed set of recent price target and rating changes from major banks. Analyst Commentary Recent research on IMCD shows a split between bullish analysts who focus on earnings potential and valuation support, and bearish analysts who are more cautious about the earnings outlook and sector headwinds.Narrative Update • Jul 24
IMCD: Fading Middle East Tailwind Will Pressure Earnings As Cyclical Headwinds Persist
The updated analyst price target for IMCD rises from €76.79 to €79.37 as analysts weigh higher fair value estimates, modestly lower discount rates, and slightly firmer assumptions for revenue growth, profit margins, and future P/E multiples following recent mixed rating changes and target increases across the Street. Analyst Commentary Recent research on IMCD highlights a split in opinion, with some firms lifting price targets and others turning more cautious on the stock's medium term outlook.Narrative Update • Jul 09
IMCD: Global Expansion And Dividend Reset Will Support Future Upside
Analysts have modestly lifted the fair value anchor for IMCD, with a price target moving from about €107.68 to €112.50 as they factor in updated assumptions on growth, margins and valuation, alongside mixed recent Street views, including a higher €105 target from Morgan Stanley and a downgrade with a €75 target from JPMorgan. Analyst Commentary Recent research on IMCD points to a split view, with some bullish analysts focusing on valuation support and others, including JPMorgan, highlighting earnings risks and less compelling pricing versus peers.
Narrative Update • Jun 25
IMCD: Dividend Support And Margin Execution Will Drive Future Re Rating Potential
Analysts have marginally lifted their fair value estimate for IMCD to about €148 per share. This reflects a blend of more cautious mid term earnings expectations cited in recent research and a higher Street price target of €105 that still sits well above a more bearish €75 view.Narrative Update • Jun 11
IMCD: Margin Execution And Earnings Quality Will Support Future Re Rating Potential
Analysts have trimmed their fair value estimate for IMCD to about €147.82 from €148.67, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E after recent mixed Street research, including a downgrade to Underweight with a €75 target and a separate target increase to €105. Analyst Commentary Recent research on IMCD points in different directions, with one high profile downgrade and more cautious earnings assumptions on one side, and a higher fair value estimate and an increased price target on the other.Narrative Update • May 28
IMCD: Fading Middle East Tailwind Will Pressure Future Earnings And Returns
Analysts now see IMCD's fair value at about €76.79, up from €75.00. The shift reflects updated views on earnings potential and valuation following mixed research, including a downgrade to Underweight with a €75 target and a separate price target increase to €105.Narrative Update • May 14
IMCD: Margin Execution And Earnings Quality Should Support Future Re Rating
Narrative update on IMCD The updated analyst price target for IMCD moves to €148.67 from €144.05. This change reflects analysts' revised views on growth, profitability and P/E assumptions after recent target changes from major banks across the sector.Narrative Update • Apr 29
IMCD: Margin Execution And Revenue Mix Should Support Future Re Rating
Analyst price targets for IMCD have edged lower, with recent cuts of €5 to €7 from several banks and a reset range between about €103 and €122. Analysts are factoring in a slightly higher discount rate, a lower assumed future P/E multiple and updated expectations for revenue growth and margins.Narrative Update • Apr 15
IMCD: Dividend Cut And Lowered Expectations Will Pressure Future Returns
IMCD's updated analyst price target has edged lower by a few euros, with recent revisions between about €103 and €122. These reflect analysts' mixed adjustments to growth, margin and P/E assumptions.Narrative Update • Mar 31
IMCD: Lower Dividend And Reset Expectations Will Set Up Future Upside
The Analyst Price Target for IMCD has shifted lower to €107.68 from €126.46, reflecting analysts' updated views on slightly softer revenue growth, thinner profit margins and a lower future P/E multiple, supported by a series of recent price target cuts and one upward revision across major banks. Analyst Commentary Recent research shows a mix of optimism and caution around IMCD, with several banks trimming price targets and one raising them, which helps explain why the average target has reset closer to current expectations.Narrative Update • Mar 17
IMCD: Sector Caution And Dividend Reset Will Shape Future Expectations
Analysts have trimmed the IMCD price target, with recent revisions clustering around €100 to €122. This reflects updated views on sector conditions and modest adjustments to revenue growth, discount rate and profit margin assumptions.Narrative Update • Mar 03
IMCD: Sector Caution And New Partnership Will Shape Future Expectations
The analyst fair value estimate for IMCD has been adjusted from €82.00 to €75.00. Analysts cite recent price target changes across major banks, along with more cautious assumptions on discount rates, revenue growth, and margins, as the key drivers of the updated view.Narrative Update • Feb 17
IMCD: Distribution Expansion And CFO Transition Will Support Future Re Rating
Analysts have trimmed their price targets for IMCD by about €14, citing slightly higher discount rate assumptions, revised profit margin expectations, and recent cautious sector views. These developments are reflected in lower price targets and a downgrade to Equal Weight.Narrative Update • Feb 03
IMCD: Cautious Sector Outlook And New Partnership Will Shape Expectations
Analysts have reduced their fair value estimate for IMCD from €107.00 to €82.00. This reflects a lower future P/E assumption and a slightly reduced profit margin outlook, in line with recent Street research that has turned more cautious on chemical distribution and related services.Narrative Update • Jan 20
IMCD: Distribution Deal And CFO Transition Will Support Sector Re Rating
Analysts have lowered their price target on IMCD to about €170.50 from roughly €176.73, citing a reset in sector expectations following cautious views on chemical distribution and a shift in preferred names within European business services. Analyst Commentary Recent research has shifted IMCD to a more neutral stance within European business services, with the rating moved to Equal Weight and the price target set at €100 from €139.Analysis Article • Jan 20
Is There An Opportunity With IMCD N.V.'s (AMS:IMCD) 50% Undervaluation?
Key Insights IMCD's estimated fair value is €148 based on 2 Stage Free Cash Flow to Equity Current share price of...Narrative Update • Jan 06
IMCD: Share Pullback Will Set Up Upside Following New Outperform Coverage
Analysts have trimmed their fair value estimate for IMCD from €127.18 to €126.46, reflecting slightly softer assumptions for revenue growth and profit margin, even as some recent research, including new Outperform coverage, points to potential upside after the recent share pullback. Analyst Commentary Bullish Takeaways Bullish analysts view the recent share pullback as creating a more appealing entry point relative to their updated fair value and the new $72.50 price target.Narrative Update • Dec 17
IMCD Will Likely Gain From New Distribution Deal And Leadership Transition
Analysts have trimmed their fair value estimate for IMCD to approximately €177 from about €182, reflecting slightly higher discount rate assumptions, more moderate revenue growth expectations, and a marginally lower future P/E, partially offset by a firmer margin outlook and recent supportive rating actions despite reduced price targets. Analyst Commentary Bullish analysts continue to frame IMCD as a quality compounder within the specialty chemicals distribution space, highlighting the recent share pullback as an opportunity rather than a sign of structural deterioration.Narrative Update • Dec 03
IMCD: Share Pullback Will Offer Opportunity As New Outperform Ratings Emerge
The analyst price target for IMCD has been trimmed modestly from EUR 131.25 to about EUR 127.18, as analysts factor in slightly slower growth and margin assumptions, even as they highlight recent upgrades and new Outperform initiations as support for a still constructive outlook. Analyst Commentary Recent research updates point to a broadly constructive stance on IMCD, with most commentary emphasizing resilient fundamentals and an attractive entry point following the share price pullback, even as some valuation and macro risks are flagged.Analysis Article • Nov 27
Some Shareholders Feeling Restless Over IMCD N.V.'s (AMS:IMCD) P/E Ratio
It's not a stretch to say that IMCD N.V.'s ( AMS:IMCD ) price-to-earnings (or "P/E") ratio of 17.6x right now seems...Narrative Update • Nov 19
IMCD: Share Pullback Will Offer Opportunity As Revenue Momentum Builds
IMCD's analyst price target has been revised down from €138.04 to €131.25. Analysts cite moderate adjustments in fair value and market outlook, despite recent supportive coverage and an improved revenue growth forecast.Analysis Article • Nov 12
Does IMCD (AMS:IMCD) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Narrative Update • Nov 04
IMCD: Share Price Pullback Will Offer Attractive Entry As Ratings Improve
The analyst fair value estimate for IMCD has been reduced from EUR 142.43 to EUR 138.04. Analysts cite more cautious assumptions on long-term revenue growth and profit margin forecasts following recent price target adjustments in Street research.Analysis Article • Oct 28
At €93.80, Is IMCD N.V. (AMS:IMCD) Worth Looking At Closely?
IMCD N.V. ( AMS:IMCD ), might not be a large cap stock, but it saw significant share price movement during recent...Narrative Update • Oct 21
Analyst Commentary Highlights Mixed Views on IMCD Amid Minor Valuation Adjustments
Analysts have slightly lowered their fair value estimate for IMCD by less than 1 percent to approximately €142.43. This reflects minor adjustments in growth expectations and recent Street research supporting a cautiously positive outlook, despite recent target downgrades.Analysis Article • Oct 12
Returns On Capital At IMCD (AMS:IMCD) Have Hit The Brakes
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...Narrative Update • Oct 03
Digitalization And M&A Will Expand Pharma And Consumer Markets
IMCD's analyst price target has decreased moderately, from €145.43 to €143.00, as analysts factor in slightly lower expected growth and a reduced profit margin outlook in recent industry assessments. Analyst Commentary Analyst opinions on IMCD remain divided as recent price target changes and rating updates reflect a mix of optimism regarding potential growth and caution due to evolving sector dynamics.Narrative Update • Sep 04
Digitalization And M&A Will Expand Pharma And Consumer Markets
Analysts cite attractive valuation, improved capital allocation, and stabilizing end markets as supportive, but near-term earnings uncertainty and ongoing macroeconomic headwinds have kept IMCD’s consensus price target unchanged at €145.43. Analyst Commentary Valuation now seen as attractive, with shares offering growth at a reasonable price.
New Narrative • Nov 25
The Company'S Digital Upgrades And M&A Strategy Ignite Growth Potential Amid Challenges
Continued organic growth through commercial excellence and digital upgrades could boost future revenue and earnings.CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2026 | n/a | n/a | €230m |
| Mar 31 2026 | n/a | n/a | €224m |
| Dec 31 2025 | €2m | €771k | €218m |
| Sep 30 2025 | n/a | n/a | €242m |
| Jun 30 2025 | n/a | n/a | €267m |
| Mar 31 2025 | n/a | n/a | €272m |
| Dec 31 2024 | €2m | €581k | €278m |
| Sep 30 2024 | n/a | n/a | €280m |
| Jun 30 2024 | n/a | n/a | €281m |
| Mar 31 2024 | n/a | n/a | €287m |
| Dec 31 2023 | €2m | €521k | €292m |
| Sep 30 2023 | n/a | n/a | €290m |
| Jun 30 2023 | n/a | n/a | €289m |
| Mar 31 2023 | n/a | n/a | €301m |
| Dec 31 2022 | €1m | €323k | €313m |
Compensation vs Market: Marcus's total compensation ($USD1.98M) is below average for companies of similar size in the Dutch market ($USD3.62M).
Compensation vs Earnings: Marcus's compensation has been consistent with company performance over the past year.
CEO
Marcus Jordan (52 yo)
4.3yrs
Tenure
€1,725,000
Compensation
Mr. Marcus C. Jordan serves as Chief Executive Officer at IMCD N.V. since May 2025. He serves as Member of Management Board at IMCD N.V. since May 02, 2022 and served as its Chief Operating Officer since M...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Member of Management Board | 4.3yrs | €1.73m | 0.027% € 1.5m | |
| CFO & Member of Management Board | 30.7yrs | €1.47m | 0.067% € 3.8m | |
| Chief Commercial Officer & Member of Management Board | less than a year | no data | 0.027% € 1.5m | |
| Head of Investor Relations | no data | no data | no data | |
| General Counsel | no data | no data | no data | |
| Corporate Communications Director | no data | no data | no data | |
| Global People Director | less than a year | no data | no data | |
| Head of Global Regulatory Questionnaire Centre | no data | no data | no data | |
| Managing Director of IMCD Mexico | 2.2yrs | no data | no data | |
| Regional President Asia-Pacific | no data | no data | no data | |
| Company Secretary | no data | no data | no data |
2.2yrs
Average Tenure
52yo
Average Age
Experienced Management: IMCD's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of Supervisory Board | 10.3yrs | €113.00k | no data | |
| Independent Vice Chairman of the Supervisory Board | 8.3yrs | €88.00k | no data | |
| Member of Supervisory Board | less than a year | no data | no data | |
| Independent Member of Supervisory Board | 4.3yrs | €82.00k | no data | |
| Independent Member of Supervisory Board | 6.3yrs | €85.00k | no data | |
| Independent Member of Supervisory Board | 2.8yrs | €74.00k | no data |
5.3yrs
Average Tenure
60.5yo
Average Age
Experienced Board: IMCD's board of directors are considered experienced (5.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/16 17:42 |
| End of Day Share Price | 2026/09/16 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
IMCD N.V. is covered by 23 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gaurav Jain | Barclays |
| James Stewart | Barclays |
| Anil Shenoy | Barclays |